Bixiye
P35-22 Medical Policy Updates: Coupe Health and Self-Funded Benefit Plans managed by Blue Cross and Blue Shield of Alabama
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2022
Natiijooyinka Raadinta
Soo bandhiga 1441 - 1450 ee natiijooyinka 4229
Bixiye
QP41-22 MHCP Pharmacy Benefit Exclusion for Opdualag™ and paclitaxel protein-bound particles
Taariikhda uu dhaqangalayo Barnaamijka: May 25, 2022
Bixiye
QP42-22 Reminder: Self-Administered Drug Coverage for Medicare Members
Taariikhda uu dhaqangalayo Barnaamijka: May 25, 2022
Bixiye
QP43-22 Reminder: Medical Drug Coding for Botulinum Toxins
Taariikhda uu dhaqangalayo Barnaamijka: May 25, 2022
Bixiye
QP44-22 Improved Provider Webpage
Taariikhda uu dhaqangalayo Barnaamijka: May 25, 2022
Bixiye
QP45-22 First Responder Mental Health Summit: Clinician Awareness Course Friday, June 24
Taariikhda uu dhaqangalayo Barnaamijka: May 25, 2022
Bixiye
QP36-22 Commercial Pharmacy Benefit Exclusion for Xolair®
Taariikhda uu dhaqangalayo Barnaamijka: May 11, 2022
Bixiye
QP37-22 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: VoxzogoTM (vosoritide)
Taariikhda uu dhaqangalayo Barnaamijka: May 11, 2022
Bixiye
QP38-22 Updates to Authorization Request with Unlisted or Unspecified Codes
Taariikhda uu dhaqangalayo Barnaamijka: May 11, 2022
Bixiye
QP40-22 Temporary Rate Increase for Personal Care Attendant (PCA) Services
Taariikhda uu dhaqangalayo Barnaamijka: May 11, 2022